JERUSALEM, November 4, 2010 /PRNewswire-FirstCall/ -- Medisafe 1 Technologies Corp. (OTCBB: MFTH), a developer of patented technologies that physically prevent unauthorized administration of prescription medications, announced today that the company will present its barcoded syringe locking-device during the HealthAchieve Conference November 8-10, in Toronto, Canada.
The presentation is expected to take place on November 8th or 9th. Manufacturers of syringes and infusion technologies, pharmaceutical companies, health insurance companies, and public relations specialists will be in attendance.
HealthAchieve is one of the largest and most prestigious health care gatherings in North America. The conference features over 50 educational sessions, and more than 350 exhibitors. HealthAchieve attracts over 9,000 health care and business leaders from around the world. To learn more about HealthAchieve, visit http://www.healthachieve.com.
"To be accepted as a presenter at the prestigious HealthAchieve Conference demonstrates that health care professionals are interested in Medisafe's patented technology," said, Jacob Elhadad, CEO of Medisafe 1 Technologies. "Our syringe locking-device is capable of significantly reducing medication administration injuries and deaths. The market potential for such a product is quite extensive."
About Medisafe 1 Technologies
Medisafe 1 Technologies seeks to effectively prevent unauthorized administration of a drug or medicinal substance by hypodermic needle. Medisafe's patented technology is a medical assembly with a locking mechanism that is intended to ensure the substance cannot be released from the hypodermic needle without positive pre-matching between the substance and its intended patient.
This letter contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 as amended and Section 21E of the Securities Exchange Act of 1934 as amended. All forward-looking statements are inherently uncertain, based on current expectations and assumptions concerning future events or future performance of Medisafe 1 Technologies Corp., and its technologies. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release, as actual results may differ materially from those indicated. Medisafe 1 Technologies Corp. public filings may be viewed at http://www.sec.gov.
Contact: Jacob Elhadad CEO +972-524440000 email@example.com
|SOURCE Medisafe 1 Technologies Corp.|
Copyright©2010 PR Newswire.
All rights reserved